First known congressional SpaceX stock buys surface after record IPO

WASHINGTON – In the immediate aftermath of SpaceX's historic public market debut, at least two members of Congress or their families acquired shares in Elon Musk's aerospace giant, according to the first publicly available financial disclosures since the offering. The transactions, while legally compliant, highlight the persistent ethical questions surrounding lawmaker investments, particularly when their committee assignments intersect with the companies they are buying.

The filings from Rep. Dan Meuser, R-Pa., and Rep. Gil Cisneros, D-Calif., represent what ethics watchdogs believe is just the beginning of a wave of disclosures expected to reveal congressional interest in one of the most anticipated initial public offerings (IPOs) on record.

The Disclosed Trades

Periodic Transaction Reports filed with the House of Representatives detail the initial congressional forays into SpaceX's public stock.

• Rep. Dan Meuser (R-Pa.): A disclosure filed by Meuser reveals that his dependent child purchased between $15,001 and $50,000 worth of SpaceX stock on June 15. The purchase is notable as it marks the first time in several years that a transaction report has shown Meuser or his immediate family buying stock in an individual company, suggesting a specific interest in the aerospace firm.

• Rep. Gil Cisneros (D-Calif.): Cisneros disclosed a personal purchase of SpaceX stock on June 18, valued between $1,001 and $15,000. Cisneros, a former member of Congress, was appointed by President Joe Biden in 2021 to serve as Under Secretary of Defense for Personnel and Readiness.

A spokesperson for Rep. Meuser did not immediately respond to a request for comment.

A Record-Shattering IPO

The trades followed SpaceX's monumental entry into the public markets, an event that reshaped the landscape for technology listings.

• Unprecedented Scale: The company went public on June 12, raising approximately $75 billion in the largest IPO in history. Shares opened at $150, and investor enthusiasm quickly pushed the company's valuation past the $2 trillion mark.

• Market Volatility: The stock has been a focal point for investors, serving as a barometer for public appetite for both Elon Musk's ventures and the burgeoning artificial intelligence sector. After reaching a closing high of $201.80 on June 16, shares have since cooled. SpaceX stock closed Thursday at $162, up about 8% from its IPO price but down significantly from its peak.

Legality, Ethics, and Committee Conflicts

Under federal law, members of Congress and their families are permitted to trade individual stocks. However, the practice is governed by rules designed to prevent conflicts of interest and insider trading.

• The STOCK Act: The Stop Trading on Congressional Knowledge (STOCK) Act of 2012 requires lawmakers to publicly disclose stock transactions made by themselves, their spouses, and their dependent children within 45 days. The law explicitly forbids them from using nonpublic information obtained through their official duties for personal financial gain.

There is no evidence that either Meuser or Cisneros violated the STOCK Act or traded on confidential information.

Despite the trades' legality, their political sensitivity is amplified by the members' committee roles, which grant them oversight of industries directly impacting SpaceX's business and valuation.

• Financial Services Oversight: Rep. Meuser is a member of the powerful House Financial Services Committee. This committee holds jurisdiction over the nation's capital markets, securities, and exchanges—the very regulatory framework that governs IPOs and stock market operations.

• Defense Department Customer: Rep. Cisneros sits on the House Armed Services Committee, which is responsible for authorizing and overseeing the Department of Defense. The Pentagon is a critical and lucrative customer for SpaceX, relying on the company for national security satellite launches, making the committee's work directly relevant to SpaceX's revenue streams.

Official Responses and Broader Context

In a statement to CNBC, Cisneros emphasized that his investments are managed independently and that he has consistently adhered to all ethics regulations.

"My wife and I have always employed outside financial advisors who have a fiduciary responsibility to maintain a diverse portfolio," Cisneros stated. "We do not manage the day-to-day trading of our investment portfolio, nor have we ever suggested a trade while serving in Congress or at the Department of Defense."

He added, "I will also continue to advocate for more ethics oversight of federally elected and politically appointed officials in regard to their financial portfolios."

The SpaceX trades are not the only recent instance of a lawmaker's finances intersecting with Musk's corporate empire.

• A Related Investment: CNBC previously reported that the husband of Rep. Lisa McClain, R-Mich., a member of House GOP leadership, purchased up to $250,000 in xAI before Musk merged the artificial intelligence startup into SpaceX. The investment positioned her family to benefit directly from the subsequent IPO. Her office stated the investments were "made in line with all House and applicable laws."

What's Next: A New Era of Tech Wealth and Scrutiny

The SpaceX filings are a preview of what is expected to be a new front in the ongoing debate over congressional ethics. As a new generation of highly valued technology companies prepares to go public, the potential for perceived conflicts of interest is set to grow.

• The Coming Wave: AI leader Anthropic has already filed confidentially for its own U.S. IPO, and rival OpenAI is reportedly targeting a listing that could value it at nearly $1 trillion. These events will present fresh opportunities for lawmakers to invest, and for watchdogs to scrutinize those investments.

• Stalled Reform Efforts: For years, bipartisan efforts to ban or severely restrict members of Congress from trading individual stocks have failed to gain traction, despite growing public support. House Republican leaders pledged late last year to hold a floor vote on a trading ban bill, but no action has been taken. A parallel proposal in the Senate advanced from committee in July 2025, but its path forward in the full chamber remains uncertain.

As more transaction reports are filed in the coming weeks, a clearer picture will emerge of just how many members of Congress sought a stake in SpaceX's historic debut. Each new disclosure will add fuel to the debate over where to draw the line between a lawmaker's right to invest and the public's right to officials free from financial conflicts of interest.